{"entity":{"type":"insider","cik":"0001256126","url":"/insider/0001256126","json_url":"/insider/0001256126.json","name":"MUELLER PETER","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":130,"n_filings":71,"first":"2005-12-21","last":"2019-08-26","span_basis":"filed_date"},"name_variants":[{"name":"MUELLER PETER","source":"filing","n_filings":71,"first_seen":"2005-12-21","last_seen":"2019-08-26"}],"transactions":[{"id":7995666,"accession":"0001104659-19-047308","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-19-047308","line_url":"/filing/0001104659-19-047308#line-1","is_derivative":false,"issuer_cik":"0001256126","issuer_name":"BioXcel Therapeutics, Inc.","issuer_ticker":"BTAI","issuer_name_source":null,"issuer_url":"/issuer/0001256126","owner_cik":"0001256126","owner_name":"MUELLER PETER","owner_display_name":"MUELLER PETER","owner_url":"/insider/0001256126","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1554.0,"shares_display":"1,554","price_per_share":9.34,"price_display":"9.34","price_state":"stated","total_value":14514.36,"total_display":"14,514.36","total_whole":"14,514","shares_owned_after":168320.0,"shares_owned_after_display":"168,320","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-23","filed_date":"2019-08-26","scope":"insider"},{"id":8667513,"accession":"0001104659-19-047150","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-19-047150","line_url":"/filing/0001104659-19-047150#line-2","is_derivative":false,"issuer_cik":"0001256126","issuer_name":"BioXcel Therapeutics, Inc.","issuer_ticker":"BTAI","issuer_name_source":null,"issuer_url":"/issuer/0001256126","owner_cik":"0001256126","owner_name":"MUELLER PETER","owner_display_name":"MUELLER PETER","owner_url":"/insider/0001256126","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6646.0,"shares_display":"6,646","price_per_share":8.83,"price_display":"8.83","price_state":"stated","total_value":58684.18,"total_display":"58,684.18","total_whole":"58,684","shares_owned_after":166766.0,"shares_owned_after_display":"166,766","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-22","filed_date":"2019-08-23","scope":"insider"},{"id":8667511,"accession":"0001104659-19-047150","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-19-047150","line_url":"/filing/0001104659-19-047150#line-1","is_derivative":false,"issuer_cik":"0001256126","issuer_name":"BioXcel Therapeutics, Inc.","issuer_ticker":"BTAI","issuer_name_source":null,"issuer_url":"/issuer/0001256126","owner_cik":"0001256126","owner_name":"MUELLER PETER","owner_display_name":"MUELLER PETER","owner_url":"/insider/0001256126","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1800.0,"shares_display":"1,800","price_per_share":8.42,"price_display":"8.42","price_state":"stated","total_value":15156.0,"total_display":"15,156.00","total_whole":"15,156","shares_owned_after":160120.0,"shares_owned_after_display":"160,120","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-21","filed_date":"2019-08-23","scope":"insider"},{"id":6905528,"accession":"0001104659-18-071881","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-18-071881","line_url":"/filing/0001104659-18-071881","is_derivative":false,"issuer_cik":"0001256126","issuer_name":"BioXcel Therapeutics, Inc.","issuer_ticker":"BTAI","issuer_name_source":null,"issuer_url":"/issuer/0001256126","owner_cik":"0001256126","owner_name":"MUELLER PETER","owner_display_name":"MUELLER PETER","owner_url":"/insider/0001256126","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7400.0,"shares_display":"7,400","price_per_share":5.009331081081081,"price_display":"5.01","price_state":"stated","total_value":37069.05,"total_display":"37,069.05","total_whole":"37,069","shares_owned_after":158320.0,"shares_owned_after_display":"158,320","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-07","filed_date":"2018-12-07","scope":"insider","n_lines":2},{"id":6905519,"accession":"0001104659-18-071881","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-18-071881","line_url":"/filing/0001104659-18-071881","is_derivative":false,"issuer_cik":"0001256126","issuer_name":"BioXcel Therapeutics, Inc.","issuer_ticker":"BTAI","issuer_name_source":null,"issuer_url":"/issuer/0001256126","owner_cik":"0001256126","owner_name":"MUELLER PETER","owner_display_name":"MUELLER PETER","owner_url":"/insider/0001256126","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1395.0,"shares_display":"1,395","price_per_share":5.000716845878136,"price_display":"5.00","price_state":"stated","total_value":6976.0,"total_display":"6,976.00","total_whole":"6,976","shares_owned_after":150820.0,"shares_owned_after_display":"150,820","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-06","filed_date":"2018-12-07","scope":"insider","n_lines":2},{"id":6117166,"accession":"0001104659-18-071741","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001104659-18-071741","line_url":"/filing/0001104659-18-071741","is_derivative":false,"issuer_cik":"0001256126","issuer_name":"BioXcel Therapeutics, Inc.","issuer_ticker":"BTAI","issuer_name_source":null,"issuer_url":"/issuer/0001256126","owner_cik":"0001256126","owner_name":"MUELLER PETER","owner_display_name":"MUELLER PETER","owner_url":"/insider/0001256126","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4007.0,"shares_display":"4,007","price_per_share":5.127070127277265,"price_display":"5.13","price_state":"stated","total_value":20544.17,"total_display":"20,544.17","total_whole":"20,544","shares_owned_after":149525.0,"shares_owned_after_display":"149,525","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-04","filed_date":"2018-12-06","scope":"insider","n_lines":5},{"id":6443835,"accession":"0001209191-14-042313","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-14-042313","line_url":"/filing/0001209191-14-042313","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001256126","owner_name":"MUELLER PETER","owner_display_name":"MUELLER PETER","owner_url":"/insider/0001256126","role":"Officer (EVP, Global R&D, CSO)","role_mark":"O","role_mark_label":"Officer (EVP, Global R&D, CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Global R&D, CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":68.31353866666667,"price_display":"68.31","price_state":"stated","total_value":512351.54,"total_display":"512,351.54","total_whole":"512,352","shares_owned_after":146614.0,"shares_owned_after_display":"146,614","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-06-16","filed_date":"2014-06-18","scope":"insider","n_lines":4},{"id":6971990,"accession":"0001209191-14-034624","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-14-034624","line_url":"/filing/0001209191-14-034624","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001256126","owner_name":"MUELLER PETER","owner_display_name":"MUELLER PETER","owner_url":"/insider/0001256126","role":"Officer (EVP, Global R&D, CSO)","role_mark":"O","role_mark_label":"Officer (EVP, Global R&D, CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Global R&D, CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":67.44653333333333,"price_display":"67.45","price_state":"stated","total_value":505849.0,"total_display":"505,849.00","total_whole":"505,849","shares_owned_after":144117.0,"shares_owned_after_display":"144,117","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-05-14","filed_date":"2014-05-16","scope":"insider","n_lines":3},{"id":6703700,"accession":"0001209191-14-028131","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-14-028131","line_url":"/filing/0001209191-14-028131","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001256126","owner_name":"MUELLER PETER","owner_display_name":"MUELLER PETER","owner_url":"/insider/0001256126","role":"Officer (EVP, Global R&D, CSO)","role_mark":"O","role_mark_label":"Officer (EVP, Global R&D, CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Global R&D, CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":61.6276,"price_display":"61.63","price_state":"stated","total_value":462207.0,"total_display":"462,207.00","total_whole":"462,207","shares_owned_after":161250.0,"shares_owned_after_display":"161,250","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-04-15","filed_date":"2014-04-17","scope":"insider","n_lines":4},{"id":6703272,"accession":"0001209191-14-021850","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-14-021850","line_url":"/filing/0001209191-14-021850","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001256126","owner_name":"MUELLER PETER","owner_display_name":"MUELLER PETER","owner_url":"/insider/0001256126","role":"Officer (EVP, Global R&D, CSO)","role_mark":"O","role_mark_label":"Officer (EVP, Global R&D, CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Global R&D, CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":78.28597333333333,"price_display":"78.29","price_state":"stated","total_value":587144.8,"total_display":"587,144.80","total_whole":"587,145","shares_owned_after":159970.0,"shares_owned_after_display":"159,970","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-17","filed_date":"2014-03-19","scope":"insider","n_lines":2},{"id":6525041,"accession":"0001209191-14-012316","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-14-012316","line_url":"/filing/0001209191-14-012316","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001256126","owner_name":"MUELLER PETER","owner_display_name":"MUELLER PETER","owner_url":"/insider/0001256126","role":"Officer (EVP, Global R&D, CSO)","role_mark":"O","role_mark_label":"Officer (EVP, Global R&D, CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Global R&D, CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":82.5922,"price_display":"82.59","price_state":"stated","total_value":619441.5,"total_display":"619,441.50","total_whole":"619,442","shares_owned_after":159383.0,"shares_owned_after_display":"159,383","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-18","filed_date":"2014-02-20","scope":"insider","n_lines":2},{"id":6586448,"accession":"0001209191-14-003731","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-003731","line_url":"/filing/0001209191-14-003731#line-2","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001256126","owner_name":"MUELLER PETER","owner_display_name":"MUELLER PETER","owner_url":"/insider/0001256126","role":"Officer (EVP, Global R&D, CSO)","role_mark":"O","role_mark_label":"Officer (EVP, Global R&D, CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Global R&D, CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":78.67,"price_display":"78.67","price_state":"stated","total_value":590025.0,"total_display":"590,025.00","total_whole":"590,025","shares_owned_after":141500.0,"shares_owned_after_display":"141,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-01-15","filed_date":"2014-01-17","scope":"insider"},{"id":4568803,"accession":"0001209191-13-057361","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-13-057361","line_url":"/filing/0001209191-13-057361","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001256126","owner_name":"MUELLER PETER","owner_display_name":"MUELLER PETER","owner_url":"/insider/0001256126","role":"Officer (EVP, Global R&D, CSO)","role_mark":"O","role_mark_label":"Officer (EVP, Global R&D, CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Global R&D, CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":64.6856,"price_display":"64.69","price_state":"stated","total_value":485142.0,"total_display":"485,142.00","total_whole":"485,142","shares_owned_after":143600.0,"shares_owned_after_display":"143,600","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-12-16","filed_date":"2013-12-17","scope":"insider","n_lines":2},{"id":5482753,"accession":"0001209191-13-056698","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-13-056698","line_url":"/filing/0001209191-13-056698#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001256126","owner_name":"MUELLER PETER","owner_display_name":"MUELLER PETER","owner_url":"/insider/0001256126","role":"Officer (EVP, Global R&D, CSO)","role_mark":"O","role_mark_label":"Officer (EVP, Global R&D, CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Global R&D, CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2900.0,"shares_display":"2,900","price_per_share":65.48,"price_display":"65.48","price_state":"stated","total_value":189892.0,"total_display":"189,892.00","total_whole":"189,892","shares_owned_after":141500.0,"shares_owned_after_display":"141,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-12-12","filed_date":"2013-12-12","scope":"insider"},{"id":4792927,"accession":"0001209191-13-053081","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-13-053081","line_url":"/filing/0001209191-13-053081","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001256126","owner_name":"MUELLER PETER","owner_display_name":"MUELLER PETER","owner_url":"/insider/0001256126","role":"Officer (EVP, Global R&D, CSO)","role_mark":"O","role_mark_label":"Officer (EVP, Global R&D, CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Global R&D, CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":62.614133333333335,"price_display":"62.61","price_state":"stated","total_value":469606.0,"total_display":"469,606.00","total_whole":"469,606","shares_owned_after":146600.0,"shares_owned_after_display":"146,600","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-11-15","filed_date":"2013-11-19","scope":"insider","n_lines":3},{"id":5189893,"accession":"0001209191-13-048645","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-13-048645","line_url":"/filing/0001209191-13-048645","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001256126","owner_name":"MUELLER PETER","owner_display_name":"MUELLER PETER","owner_url":"/insider/0001256126","role":"Officer (EVP, Global R&D, CSO)","role_mark":"O","role_mark_label":"Officer (EVP, Global R&D, CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Global R&D, CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":73.248608,"price_display":"73.25","price_state":"stated","total_value":549364.56,"total_display":"549,364.56","total_whole":"549,365","shares_owned_after":145066.0,"shares_owned_after_display":"145,066","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-10-15","filed_date":"2013-10-17","scope":"insider","n_lines":2},{"id":4609854,"accession":"0001209191-13-044599","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-13-044599","line_url":"/filing/0001209191-13-044599","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001256126","owner_name":"MUELLER PETER","owner_display_name":"MUELLER PETER","owner_url":"/insider/0001256126","role":"Officer (EVP, Global R&D, CSO)","role_mark":"O","role_mark_label":"Officer (EVP, Global R&D, CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Global R&D, CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":77.22138666666666,"price_display":"77.22","price_state":"stated","total_value":579160.4,"total_display":"579,160.40","total_whole":"579,160","shares_owned_after":148815.0,"shares_owned_after_display":"148,815","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-09-16","filed_date":"2013-09-17","scope":"insider","n_lines":4},{"id":4609732,"accession":"0001209191-13-041331","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-13-041331","line_url":"/filing/0001209191-13-041331","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001256126","owner_name":"MUELLER PETER","owner_display_name":"MUELLER PETER","owner_url":"/insider/0001256126","role":"Officer (EVP, Global R&D, CSO)","role_mark":"O","role_mark_label":"Officer (EVP, Global R&D, CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Global R&D, CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":77.408,"price_display":"77.41","price_state":"stated","total_value":580560.0,"total_display":"580,560.00","total_whole":"580,560","shares_owned_after":147400.0,"shares_owned_after_display":"147,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-08-15","filed_date":"2013-08-19","scope":"insider","n_lines":2},{"id":5539070,"accession":"0001209191-13-037015","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-13-037015","line_url":"/filing/0001209191-13-037015","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001256126","owner_name":"MUELLER PETER","owner_display_name":"MUELLER PETER","owner_url":"/insider/0001256126","role":"Officer (EVP, Global R&D, CSO)","role_mark":"O","role_mark_label":"Officer (EVP, Global R&D, CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Global R&D, CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":86.33562,"price_display":"86.34","price_state":"stated","total_value":647517.15,"total_display":"647,517.15","total_whole":"647,517","shares_owned_after":146935.0,"shares_owned_after_display":"146,935","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-07-15","filed_date":"2013-07-17","scope":"insider","n_lines":2},{"id":4372476,"accession":"0001209191-13-035485","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-13-035485","line_url":"/filing/0001209191-13-035485","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001256126","owner_name":"MUELLER PETER","owner_display_name":"MUELLER PETER","owner_url":"/insider/0001256126","role":"Officer (EVP, Global R&D, CSO)","role_mark":"O","role_mark_label":"Officer (EVP, Global R&D, CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Global R&D, CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":122300.0,"shares_display":"122,300","price_per_share":79.7950278004906,"price_display":"79.80","price_state":"stated","total_value":9758931.9,"total_display":"9,758,931.90","total_whole":"9,758,932","shares_owned_after":183765.0,"shares_owned_after_display":"183,765","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-07-02","filed_date":"2013-07-03","scope":"insider","n_lines":3},{"id":2410711,"accession":"0001209191-12-049586","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-12-049586","line_url":"/filing/0001209191-12-049586","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001256126","owner_name":"MUELLER PETER","owner_display_name":"MUELLER PETER","owner_url":"/insider/0001256126","role":"Officer (EVP, Global R&D, CSO)","role_mark":"O","role_mark_label":"Officer (EVP, Global R&D, CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Global R&D, CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6500.0,"shares_display":"6,500","price_per_share":52.925384615384615,"price_display":"52.93","price_state":"stated","total_value":344015.0,"total_display":"344,015.00","total_whole":"344,015","shares_owned_after":134316.0,"shares_owned_after_display":"134,316","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-10-15","filed_date":"2012-10-16","scope":"insider","n_lines":2},{"id":3191320,"accession":"0001209191-12-046196","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-12-046196","line_url":"/filing/0001209191-12-046196#line-2","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001256126","owner_name":"MUELLER PETER","owner_display_name":"MUELLER PETER","owner_url":"/insider/0001256126","role":"Officer (EVP, Global R&D, CSO)","role_mark":"O","role_mark_label":"Officer (EVP, Global R&D, CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Global R&D, CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6500.0,"shares_display":"6,500","price_per_share":57.52,"price_display":"57.52","price_state":"stated","total_value":373880.0,"total_display":"373,880.00","total_whole":"373,880","shares_owned_after":132316.0,"shares_owned_after_display":"132,316","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-09-17","filed_date":"2012-09-19","scope":"insider"}],"collapsed":true,"next_cursor":"2012-09-17|3191320","ledger_fault":false,"count":{"value":130,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":12,"open_market":true},{"code":"S","label":"Open-market sale","n":118,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":130},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001720893","name":"BioXcel Therapeutics, Inc.","url":"/issuer/0001720893","role":"Director","n_filings":4,"first_seen":"2018-12-06","last_seen":"2019-08-26"},{"type":"issuer","type_label":"ISSUER","cik":"0000875320","name":"VERTEX PHARMACEUTICALS INC / MA","url":"/issuer/0000875320","role":"Officer (EVP, Global R&D, CSO)","n_filings":67,"first_seen":"2005-12-21","last_seen":"2014-06-18"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001256126","retrieved_at":"2026-08-23T18:57:51+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}